OMIX

Circulating Tumor DNA for Molecular Residual Disease Detection in Epithelial Ovarian Cancer

OMIX007276

1Summary
Title Circulating Tumor DNA for Molecular Residual Disease Detection in Epithelial Ovarian Cancer
Description This project investigates the use of circulating tumor DNA (ctDNA) for the detection of molecular residual disease (MRD) in patients with epithelial ovarian cancer (EOC) who have undergone primary debulking surgery and adjuvant chemotherapy. Despite standard treatments, EOC patients often face relapse, highlighting the need for effective post-treatment monitoring. By analyzing ctDNA in plasma samples collected before and after treatment, alongside tumor tissue sequencing, we aim to identify tumor-specific genetic variants that could serve as early warning signs for potential relapse. This approach has the potential to improve post-operative surveillance and contribute to more personalized treatment strategies for EOC patients.
Organism Homo sapiens
Data Type Other Type of Genomic Data
Data Accessibility Open-access
BioProject PRJCA029849
Release Date 2024-11-18
Submitter Yang Xiang (xiangy@pumch.cn)
Organization Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Submission Date 2024-09-04
2Files & Download

The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX007276-01 Mutation list of 51 epithelial ovarian cancer tissues 1 Other Type of Genomic Data 24.7 KB txt 0 Unavailable
OMIX007276-02 Mutation list of baseline blood 1 Other Type of Genomic Data 16.6 KB txt 0 Unavailable
OMIX007276-03 Mutation list of post-surgery blood 1 Other Type of Genomic Data 2.6 KB txt 0 Unavailable
OMIX007276-04 Mutation list of post-adjuvant chemotherapy blood 1 Other Type of Genomic Data 718 bytes txt 0 Unavailable

View All Released Data of OMIX